Terns Pharmaceuticals, Inc. (TERN)
NASDAQ: TERN · Real-Time Price · USD
6.89
+0.01 (0.15%)
At close: Oct 30, 2024, 4:00 PM
6.82
-0.07 (-1.02%)
After-hours: Oct 30, 2024, 5:03 PM EDT
Terns Pharmaceuticals Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
66
Market Cap
581.76M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Pharming Group | 285.75M |
| Pacific Biosciences of California | 188.87M |
| SI-BONE | 150.71M |
| Allogene Therapeutics | 65.00K |
| Q32 Bio | -12.80M |
TERN News
- 23 days ago - Terns Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4) - GlobeNewsWire
- 5 weeks ago - Terns Pharmaceuticals: Obesity Advancement Continues With Other Q1 2025 Program Catalyst - Seeking Alpha
- 6 weeks ago - Undercovered Stock Picks From September 6-12: Lithium, Uranium, Gold, & Plastic - Seeking Alpha
- 6 weeks ago - Terns Announces Closing of Public Offering of Shares of Common Stock and Pre-Funded Warrants, Including Full Exercise of Underwriters' Option to Purchase Additional Shares - GlobeNewsWire
- 7 weeks ago - Terns Announces Pricing of Upsized $150.15 Million Public Offering - GlobeNewsWire
- 7 weeks ago - Terns Pharmaceuticals: Weight Loss Drug TERN-601 Is Competitive - Seeking Alpha
- 7 weeks ago - Terns Announces Proposed Public Offering - GlobeNewsWire
- 7 weeks ago - Terns Pharmaceuticals Stock Is Soaring on Good Data for Weight-Loss Pill - Barrons